Efficacy and Safety of Satralizumab for Thyroid Eye Disease: Week 24 Results from the Phase 3 SatraGO-1 and SatraGO-2 Randomized Trials.

César A Briceño, Oluwatobi O Idowu, Jwu Jin Khong, Thomas Kuenzel, Ann Q Tran, Christopher Brittain, Atsushi Azumi, Laura Brockwell, Nima Ghadiri, Mariano Coronel, Thorsten Ruf, Dongmei Li, Mario Salvi, Antonio Manuel Garrido-Hermosilla, Giulio Barteselli, Santiago Ortiz-Perez, of the SatraGO-1 and SatraGO-2 investigators

DOI: 10.1016/j.ophtha.2026.08.039